Literature DB >> 22080472

In-hospital follow-up of implantable cardioverter defibrillator and pacemaker carriers: patients' inconvenience and points of view. A four-hospital Italian survey.

Lorena Gramegna1, Claudia Tomasi, Gianni Gasparini, Greta Scaboro, Francesco Zanon, Graziano Boaretto, Ruggero Tomei, Luca Tomasi.   

Abstract

AIMS: The increasing volume of pacemaker (PM) and implantable cardioverter defibrillator (ICD) implants and problems related to their functioning have highlighted the issue of device follow-ups. Patients' convenience regarding device visits has been little investigated. This work aims at surveying patients' efforts in attending the in-office PM/ICD follow-ups and at evaluating their expectations. METHODS AND
RESULTS: In four Italian referral centres, over a 3-month period, a 20-point questionnaire was completed by all consecutive patients at in-hospital PM/ICD visits. In total, 1109 questionnaire/patients were evaluated. Pacemakers were 68%, ICDs 16%, and cardiac resynchronizations (CRTs) (PM + ICD) 16%; 38% were females; mean age was 75 ± 11 years. Almost all were scheduled visits. There was frequent reprogramming and clinical examination, even after 6 months from implant. Perceived inconvenience for the in-office follow-up was relevant in 35% of cases; attitudes towards remote monitoring were positive in 88% of cases. Inter-group analysis showed some significant difference: PM patients were older and more frequently female; ICD carriers were younger, had the highest rate of clinical evaluation, a longer journey time, and the most positive opinion about remote follow-up. Cardiac resynchronization patients had a longer waiting time and the lowest inconvenience. Overall inconvenience was independently predicted by increasing age, lengthy travelling times, and being accompanied; favourable opinions about remote monitoring were predicted by overall inconvenience, and, in ICD carriers only, by lack of clinical examination.
CONCLUSIONS: Patients' perceptions of in-hospital PM/ICD visits were affected by age and by journey modalities. Individual factors seem to affect both opinions about in-office visits and expectations towards a possible remote follow-up.

Entities:  

Mesh:

Year:  2011        PMID: 22080472     DOI: 10.1093/europace/eur334

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  Impact of in-clinic follow-up visits in patients with implantable cardioverter defibrillators: demographic and socioeconomic analysis of the TARIFF study population.

Authors:  Renato P Ricci; Alfredo Vicentini; Antonio D'Onofrio; Antonio Sagone; Antonio Vincenti; Luigi Padeletti; Loredana Morichelli; Antonio Fusco; Filippo Vecchione; Francesco Lo Presti; Alessandra Denaro; Annalisa Pollastrelli; Massimo Santini
Journal:  J Interv Card Electrophysiol       Date:  2013-09-21       Impact factor: 1.900

2.  Implantable cardioverter defibrillator remote monitoring is well accepted and easy to use during long-term follow-up.

Authors:  Loredana Morichelli; Antonio Porfili; Laura Quarta; Anna Sassi; Renato Pietro Ricci
Journal:  J Interv Card Electrophysiol       Date:  2014-09-26       Impact factor: 1.900

3.  Remote monitoring for implantable defibrillators: a nationwide survey in Italy.

Authors:  Mario Luzi; Antonio De Simone; Loira Leoni; Claudia Amellone; Ennio Pisanò; Stefano Favale; Massimo Iacoviello; Raffaele Luise; Maria Grazia Bongiorni; Giuseppe Stabile; Vincenzo La Rocca; Franco Folino; Alessandro Capucci; Antonio D'Onofrio; Francesco Accardi; Sergio Valsecchi; Gianfranco Buia
Journal:  Interact J Med Res       Date:  2013-09-20

4.  Cost-utility analysis of telemonitoring versus conventional hospital-based follow-up of patients with pacemakers. The NORDLAND randomized clinical trial.

Authors:  Antonio Lopez-Villegas; Daniel Catalan-Matamoros; Salvador Peiro; Knut Tore Lappegard; Remedios Lopez-Liria
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

Review 5.  Knowledge Update on the Economic Evaluation of Pacemaker Telemonitoring Systems.

Authors:  Antonio Lopez-Villegas; César Leal-Costa; Mercedes Perez-Heredia; Irene Villegas-Tripiana; Daniel Catalán-Matamoros
Journal:  Int J Environ Res Public Health       Date:  2021-11-18       Impact factor: 3.390

6.  Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial.

Authors:  Gerhard Hindricks; Christian Elsner; Christopher Piorkowski; Milos Taborsky; Jan Christoph Geller; Burghard Schumacher; Jan Bytesnik; Hans Kottkamp
Journal:  Eur Heart J       Date:  2013-07-18       Impact factor: 29.983

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.